Explore / Clinical trial
Clinical trial

Psilocybin - Induced Neuroplasticity in the Treatment of Major Depressive Disorder

Yale UniversityActive, not recruitingPhase 1Started Feb 27, 201818 enrolledUnited StatesNCT03554174

Abstract

The primary goal of this pilot study is to investigate whether psilocybin alters neuroplasticity in people with major depressive disorder. The primary hypothesis is that psilocybin will result in neuroplastic changes that parallel improvement in symptoms of depression.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

PsilocybinDepression

Keywords

Major Depressive Disorder

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.